U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879197) titled 'Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer' on March 11.
Brief Summary: We evaluated all related clinical and pathologic data of patients with Locally Advanced Rectal Cancer following Neoadjuvant Chemoradiotherapy, including the pathologic regression grading, and other histopathologic characteristics. Finally, the present study was aimed at (1) clarifying the clinical significance of the Major Pathologic Regression for Locally Advanced Rectal Cancer following Locally Advanced Rectal Cancer and (2) comparing different Neoadjuvant Chemoradiotherapy treatments of this uncommon disease through ...